Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience
• Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes.
Gespeichert in:
| Autor*in: |
Dholaria, Bhagirathbhai R. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
Allogeneic bone marrow transplantation |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: N - Li, Danyang ELSEVIER, 2019, clinical and laboratory studies, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:67 ; year:2018 ; pages:1-5 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.leukres.2018.01.009 |
|---|
| Katalog-ID: |
ELV042413605 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV042413605 | ||
| 003 | DE-627 | ||
| 005 | 20230624095536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.leukres.2018.01.009 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000184A.pica |
| 035 | |a (DE-627)ELV042413605 | ||
| 035 | |a (ELSEVIER)S0145-2126(18)30015-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 333.7 |a 610 |q VZ |
| 084 | |a 43.12 |2 bkl | ||
| 084 | |a 43.13 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Dholaria, Bhagirathbhai R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience |
| 264 | 1 | |c 2018 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. | ||
| 650 | 7 | |a Graft versus host disease |2 Elsevier | |
| 650 | 7 | |a Allogeneic bone marrow transplantation |2 Elsevier | |
| 650 | 7 | |a T- cell prolymphocytic leukemia |2 Elsevier | |
| 650 | 7 | |a Relapse/progression |2 Elsevier | |
| 650 | 7 | |a Overall survival |2 Elsevier | |
| 650 | 7 | |a Non- relapse mortality |2 Elsevier | |
| 700 | 1 | |a Ayala, Ernesto |4 oth | |
| 700 | 1 | |a Sokol, Lubomir |4 oth | |
| 700 | 1 | |a Nishihori, Taiga |4 oth | |
| 700 | 1 | |a Chavez, Julio C. |4 oth | |
| 700 | 1 | |a Hussaini, Mohammad |4 oth | |
| 700 | 1 | |a Kumar, Ambuj |4 oth | |
| 700 | 1 | |a Kharfan-Dabaja, Mohamed A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Li, Danyang ELSEVIER |t N |d 2019 |d clinical and laboratory studies |g Amsterdam [u.a.] |w (DE-627)ELV002185202 |
| 773 | 1 | 8 | |g volume:67 |g year:2018 |g pages:1-5 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.leukres.2018.01.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-GGO | ||
| 936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
| 936 | b | k | |a 43.13 |j Umwelttoxikologie |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 67 |j 2018 |h 1-5 |g 5 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
b r d br brd |
|---|---|
| matchkey_str |
dholariabhagirathbhairayalaernestosokoll:2018----:loeeceaooeicltaslnainnclpoypoyilue |
| hierarchy_sort_str |
2018 |
| bklnumber |
43.12 43.13 44.13 |
| publishDate |
2018 |
| allfields |
10.1016/j.leukres.2018.01.009 doi GBV00000000000184A.pica (DE-627)ELV042413605 (ELSEVIER)S0145-2126(18)30015-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dholaria, Bhagirathbhai R. verfasserin aut Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience 2018 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Elsevier Ayala, Ernesto oth Sokol, Lubomir oth Nishihori, Taiga oth Chavez, Julio C. oth Hussaini, Mohammad oth Kumar, Ambuj oth Kharfan-Dabaja, Mohamed A. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:67 year:2018 pages:1-5 extent:5 https://doi.org/10.1016/j.leukres.2018.01.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 67 2018 1-5 5 045F 610 |
| spelling |
10.1016/j.leukres.2018.01.009 doi GBV00000000000184A.pica (DE-627)ELV042413605 (ELSEVIER)S0145-2126(18)30015-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dholaria, Bhagirathbhai R. verfasserin aut Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience 2018 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Elsevier Ayala, Ernesto oth Sokol, Lubomir oth Nishihori, Taiga oth Chavez, Julio C. oth Hussaini, Mohammad oth Kumar, Ambuj oth Kharfan-Dabaja, Mohamed A. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:67 year:2018 pages:1-5 extent:5 https://doi.org/10.1016/j.leukres.2018.01.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 67 2018 1-5 5 045F 610 |
| allfields_unstemmed |
10.1016/j.leukres.2018.01.009 doi GBV00000000000184A.pica (DE-627)ELV042413605 (ELSEVIER)S0145-2126(18)30015-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dholaria, Bhagirathbhai R. verfasserin aut Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience 2018 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Elsevier Ayala, Ernesto oth Sokol, Lubomir oth Nishihori, Taiga oth Chavez, Julio C. oth Hussaini, Mohammad oth Kumar, Ambuj oth Kharfan-Dabaja, Mohamed A. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:67 year:2018 pages:1-5 extent:5 https://doi.org/10.1016/j.leukres.2018.01.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 67 2018 1-5 5 045F 610 |
| allfieldsGer |
10.1016/j.leukres.2018.01.009 doi GBV00000000000184A.pica (DE-627)ELV042413605 (ELSEVIER)S0145-2126(18)30015-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dholaria, Bhagirathbhai R. verfasserin aut Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience 2018 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Elsevier Ayala, Ernesto oth Sokol, Lubomir oth Nishihori, Taiga oth Chavez, Julio C. oth Hussaini, Mohammad oth Kumar, Ambuj oth Kharfan-Dabaja, Mohamed A. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:67 year:2018 pages:1-5 extent:5 https://doi.org/10.1016/j.leukres.2018.01.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 67 2018 1-5 5 045F 610 |
| allfieldsSound |
10.1016/j.leukres.2018.01.009 doi GBV00000000000184A.pica (DE-627)ELV042413605 (ELSEVIER)S0145-2126(18)30015-8 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dholaria, Bhagirathbhai R. verfasserin aut Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience 2018 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Elsevier Ayala, Ernesto oth Sokol, Lubomir oth Nishihori, Taiga oth Chavez, Julio C. oth Hussaini, Mohammad oth Kumar, Ambuj oth Kharfan-Dabaja, Mohamed A. oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:67 year:2018 pages:1-5 extent:5 https://doi.org/10.1016/j.leukres.2018.01.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 67 2018 1-5 5 045F 610 |
| language |
English |
| source |
Enthalten in N Amsterdam [u.a.] volume:67 year:2018 pages:1-5 extent:5 |
| sourceStr |
Enthalten in N Amsterdam [u.a.] volume:67 year:2018 pages:1-5 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Umweltchemie Umwelttoxikologie Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
Graft versus host disease Allogeneic bone marrow transplantation T- cell prolymphocytic leukemia Relapse/progression Overall survival Non- relapse mortality |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
N |
| authorswithroles_txt_mv |
Dholaria, Bhagirathbhai R. @@aut@@ Ayala, Ernesto @@oth@@ Sokol, Lubomir @@oth@@ Nishihori, Taiga @@oth@@ Chavez, Julio C. @@oth@@ Hussaini, Mohammad @@oth@@ Kumar, Ambuj @@oth@@ Kharfan-Dabaja, Mohamed A. @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002185202 |
| dewey-sort |
3610 |
| id |
ELV042413605 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV042413605</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624095536.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2018.01.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000184A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV042413605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(18)30015-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dholaria, Bhagirathbhai R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Graft versus host disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Allogeneic bone marrow transplantation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T- cell prolymphocytic leukemia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Relapse/progression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Overall survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non- relapse mortality</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ayala, Ernesto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sokol, Lubomir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nishihori, Taiga</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chavez, Julio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hussaini, Mohammad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Ambuj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kharfan-Dabaja, Mohamed A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:67</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1-5</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2018.01.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">67</subfield><subfield code="j">2018</subfield><subfield code="h">1-5</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Dholaria, Bhagirathbhai R. |
| spellingShingle |
Dholaria, Bhagirathbhai R. ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience |
| authorStr |
Dholaria, Bhagirathbhai R. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002185202 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 333 - Economics of land & energy |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality Elsevier |
| topic |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality |
| topic_unstemmed |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality |
| topic_browse |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Graft versus host disease Elsevier Allogeneic bone marrow transplantation Elsevier T- cell prolymphocytic leukemia Elsevier Relapse/progression Elsevier Overall survival Elsevier Non- relapse mortality |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
e a ea l s ls t n tn j c c jc jcc m h mh a k ak m a k d mak makd |
| hierarchy_parent_title |
N |
| hierarchy_parent_id |
ELV002185202 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
N |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002185202 |
| title |
Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience |
| ctrlnum |
(DE-627)ELV042413605 (ELSEVIER)S0145-2126(18)30015-8 |
| title_full |
Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience |
| author_sort |
Dholaria, Bhagirathbhai R. |
| journal |
N |
| journalStr |
N |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
1 |
| author_browse |
Dholaria, Bhagirathbhai R. |
| container_volume |
67 |
| physical |
5 |
| class |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Dholaria, Bhagirathbhai R. |
| doi_str_mv |
10.1016/j.leukres.2018.01.009 |
| dewey-full |
610 333.7 |
| title_sort |
allogeneic hematopoietic cell transplantation in t-cell prolymphocytic leukemia: a single-center experience |
| title_auth |
Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience |
| abstract |
• Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. |
| abstractGer |
• Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. |
| abstract_unstemmed |
• Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO |
| title_short |
Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience |
| url |
https://doi.org/10.1016/j.leukres.2018.01.009 |
| remote_bool |
true |
| author2 |
Ayala, Ernesto Sokol, Lubomir Nishihori, Taiga Chavez, Julio C. Hussaini, Mohammad Kumar, Ambuj Kharfan-Dabaja, Mohamed A. |
| author2Str |
Ayala, Ernesto Sokol, Lubomir Nishihori, Taiga Chavez, Julio C. Hussaini, Mohammad Kumar, Ambuj Kharfan-Dabaja, Mohamed A. |
| ppnlink |
ELV002185202 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.leukres.2018.01.009 |
| up_date |
2024-07-06T22:44:03.348Z |
| _version_ |
1803871419996569600 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV042413605</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624095536.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2018.01.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000184A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV042413605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(18)30015-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dholaria, Bhagirathbhai R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Allogenic cell transplantation is effective therapy for patients with T-cell Prolymphocytic Leukemia. • Non-relapse mortality and relapse remain limitations of transplant efficacy. • Post-transplant strategies may help to further improve outcomes.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Graft versus host disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Allogeneic bone marrow transplantation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">T- cell prolymphocytic leukemia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Relapse/progression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Overall survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non- relapse mortality</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ayala, Ernesto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sokol, Lubomir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nishihori, Taiga</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chavez, Julio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hussaini, Mohammad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Ambuj</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kharfan-Dabaja, Mohamed A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:67</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1-5</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2018.01.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">67</subfield><subfield code="j">2018</subfield><subfield code="h">1-5</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3985157 |